Grifols S.A. ADR (GRFS)

$8.71 0.00 (0.00%)

16:00 EDT GRFS Stock Quote Delayed 30 Minutes

7 Pharmaceutical Stocks to Buy for Post-Pandemic Gains

By Louis Navellier and the InvestorPlace Research Staff Jun 9, 2020

Much of the conversation about pharmaceutical stocks rests on the coronavirus, but these high-growth names have potential beyond the pandemic.

2 Stable and 2 Speculative Biotech Stocks to Buy

Biggest Movers in Manufacturing Stocks Now – BOSC TCON VTVT GRFS

13 Biotechnology Stocks to Sell Now

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 2,970

Day's Range -

52-Week Range $5.71 - $13.10

Dividend & Yield N/A (N/A)

GRFS Stock Predictions, Articles, and Grifols S.A. ADR News

From InvestorPlace
From the Web

23 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 26, 2016

This week, the overall grades of 23 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

11 Biotechnology Stocks to Buy Now

By Portfolio Grader Jun 6, 2016

The grades of 11 Biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

40 Upgrades and Downgrades for this Week

By Louis Navellier, Editor, Growth Investor Jun 1, 2016

It pays to stay on top of the latest profit opportunities, and today's post is a great place to start. Here are Portfolio Grader's latest stock updates

73 Stock Trades for Your Week

By Louis Navellier, Editor, Growth Investor Mar 8, 2016

During these times it pays to stay on top of the latest profit opportunities. Today's blog post should be a great place to start with these 73 stock trades

Investor Alert: Know Before You Buy These 57 Blue Chips

By Louis Navellier, Editor, Growth Investor Mar 1, 2016

It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with the latest Portfolio Grader marks

64 Actions to Take on Monday’s Market Dip

By Louis Navellier, Editor, Growth Investor Feb 9, 2016

It pays to stay on top of the latest profit opportunities, and today's blog post is a great place to start after Monday's route

7 Healthcare Stocks to Kick to the Curb

By Louis Navellier, Editor, Growth Investor Jun 26, 2015

Not all stocks in the healthcare sector have bright prospects moving forward. These seven healthcare stocks are dogs that are best to be avoided, for now.